Invention Grant
- Patent Title: Melanoma antigen peptide and uses thereof
- Patent Title (中): 黑素瘤抗原肽及其用途
-
Application No.: US14086067Application Date: 2013-11-21
-
Publication No.: US08975371B2Publication Date: 2015-03-10
- Inventor: Nathalie Labarriere , Agnes Moreau-Aubry , Yann Godet
- Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale) , Universite de Nantes , Chu Nantes
- Applicant Address: FR Paris FR Nantes FR Nantes
- Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),Universite de Nantes,Chu Nantes
- Current Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),Universite de Nantes,Chu Nantes
- Current Assignee Address: FR Paris FR Nantes FR Nantes
- Agency: McAndrews Held & Malloy, Ltd.
- Priority: EP08305517 20080902
- Main IPC: C07K7/00
- IPC: C07K7/00 ; C07K7/06 ; A61K39/00 ; C07K14/47 ; G01N33/574
Abstract:
The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.
Public/Granted literature
- US20140088290A1 Novel Melanoma Antigen Peptide and Uses Thereof Public/Granted day:2014-03-27
Information query
